DVL1 Polyclonal Antibody

DVL1, the human homolog of the Drosophila dishevelled gene (dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 is a candidate gene for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development.

The DVL1 Polyclonal Antibody is a highly reliable and efficient tool designed for the detection and analysis of Dishevelled segment polarity protein 1 (DVL1). This antibody is produced using advanced polyclonal antibody technology, ensuring exceptional specificity and sensitivity in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The DVL1 Polyclonal Antibody exhibits outstanding performance in the identification and characterization of DVL1 protein expression in diverse biological samples. It recognizes the target protein with high affinity, enabling accurate and precise quantification. This antibody is meticulously validated to ensure consistent and reproducible results, making it an ideal choice for both research and diagnostic purposes.

With its superior quality and reliability, the DVL1 Polyclonal Antibody offers researchers and clinicians a valuable tool for investigating the role of DVL1 in various cellular processes and disease mechanisms. Its versatility and compatibility with multiple experimental techniques make it an indispensable asset in the field of molecular biology and biomedical research.

Order the DVL1 Polyclonal Antibody today and unlock new insights into the intricate workings of DVL1, advancing scientific knowledge and paving the way for innovative therapeutic interventions.